PROMUS PREMIER?
Report
- Report Number
- 2134265-2014-08275
- Event Type
- Injury
- Date Received
- January 7, 2015
- Date of Event
- July 4, 2014
- Report Date
- December 12, 2014
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P110010
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(6). DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
(B)(4). IT WAS REPORTED THAT CORONARY ARTERY DISSECTION OCCURRED. IN (B)(6) 2014, THE PATIENT PRESENTED DUE TO ASYMPTOMATIC ISCHEMIA AND PERCUTANEOUS CORONARY INTERVENTION (PCI) WAS PERFORMED. THE 15 X 2.3 MM, NEW, CONCENTRIC, TYPE B1 AND 90% STENOSED TARGET LESION CONTAINED IN A <= 45 DEGREE ANGULATION AND WITH TMI FLOW 3 WAS LOCATED IN THE MID-DISTAL LEFT ANTERIOR DESCENDING (LAD) ARTERY. THE LESION WAS TREATED WITH PLACEMENT OF A 2.25 MM PROMUS PREMIER OUE MR DRUG ELUTING STENT. FOLLOWING POST DILATATION, CORONARY ARTERY DISSECTION WAS NOTED IN THE DISTAL LAD AND A 16 X 2.25 PROMUS PREMIER OUS MR WAS DEPLOYED AT 8 ATMOSPHERES TO TREAT THE DISSECTION. POST PROCEDURE, TMI FLOW 3 WAS RESTORED WITH 0% VISUAL RESIDUAL STENOSIS. THE EVENT WAS CONSIDERED RESOLVED. THE PHYSICIAN THOUGHT THAT THE 1ST STENT (2.25 PROMUS PREMIER STENT) WAS THE CAUSE OF THE DISSECTION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 12189 | PROMUS PREMIER? | STENT, CORONARY, DRUG-ELUTING | NIQ | BOSTON SCIENTIFIC - GALWAY | UNK758 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Required Intervention |